Neuroimaging-Based Classification Algorithm for Predicting 1p/19q-Codeletion Status in IDH-Mutant Lower Grade Gliomas
- PMID: 30705071
- PMCID: PMC7028667
- DOI: 10.3174/ajnr.A5957
Neuroimaging-Based Classification Algorithm for Predicting 1p/19q-Codeletion Status in IDH-Mutant Lower Grade Gliomas
Abstract
Background and purpose: Isocitrate dehydrogenase (IDH)-mutant lower grade gliomas are classified as oligodendrogliomas or diffuse astrocytomas based on 1p/19q-codeletion status. We aimed to test and validate neuroradiologists' performances in predicting the codeletion status of IDH-mutant lower grade gliomas based on simple neuroimaging metrics.
Materials and methods: One hundred two IDH-mutant lower grade gliomas with preoperative MR imaging and known 1p/19q status from The Cancer Genome Atlas composed a training dataset. Two neuroradiologists in consensus analyzed the training dataset for various imaging features: tumor texture, margins, cortical infiltration, T2-FLAIR mismatch, tumor cyst, T2* susceptibility, hydrocephalus, midline shift, maximum dimension, primary lobe, necrosis, enhancement, edema, and gliomatosis. Statistical analysis of the training data produced a multivariate classification model for codeletion prediction based on a subset of MR imaging features and patient age. To validate the classification model, 2 different independent neuroradiologists analyzed a separate cohort of 106 institutional IDH-mutant lower grade gliomas.
Results: Training dataset analysis produced a 2-step classification algorithm with 86.3% codeletion prediction accuracy, based on the following: 1) the presence of the T2-FLAIR mismatch sign, which was 100% predictive of noncodeleted lower grade gliomas, (n = 21); and 2) a logistic regression model based on texture, patient age, T2* susceptibility, primary lobe, and hydrocephalus. Independent validation of the classification algorithm rendered codeletion prediction accuracies of 81.1% and 79.2% in 2 independent readers. The metrics used in the algorithm were associated with moderate-substantial interreader agreement (κ = 0.56-0.79).
Conclusions: We have validated a classification algorithm based on simple, reproducible neuroimaging metrics and patient age that demonstrates a moderate prediction accuracy of 1p/19q-codeletion status among IDH-mutant lower grade gliomas.
© 2019 by American Journal of Neuroradiology.
Figures



Similar articles
-
The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance.Neurosurg Focus. 2019 Dec 1;47(6):E13. doi: 10.3171/2019.9.FOCUS19660. Neurosurg Focus. 2019. PMID: 31786548
-
MRI Scoring Systems for Predicting Isocitrate Dehydrogenase Mutation and Chromosome 1p/19q Codeletion in Adult-type Diffuse Glioma Lacking Contrast Enhancement.Radiology. 2024 May;311(2):e233120. doi: 10.1148/radiol.233120. Radiology. 2024. PMID: 38713025
-
Predicting 1p/19q codeletion status using diffusion-, susceptibility-, perfusion-weighted, and conventional MRI in IDH-mutant lower-grade gliomas.Acta Radiol. 2021 Dec;62(12):1657-1665. doi: 10.1177/0284185120973624. Epub 2020 Nov 22. Acta Radiol. 2021. PMID: 33222488
-
Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign.Eur Radiol. 2020 Feb;30(2):844-854. doi: 10.1007/s00330-019-06395-2. Epub 2019 Aug 24. Eur Radiol. 2020. PMID: 31446467
-
The T2-FLAIR mismatch sign as a predictor of IDH-mutant, 1p/19q-noncodeleted lower-grade gliomas: a systematic review and diagnostic meta-analysis.Eur Radiol. 2021 Jul;31(7):5289-5299. doi: 10.1007/s00330-020-07467-4. Epub 2021 Jan 6. Eur Radiol. 2021. PMID: 33409784
Cited by
-
Clinical Imaging for Diagnostic Challenges in the Management of Gliomas: A Review.J Neuroimaging. 2020 Mar;30(2):139-145. doi: 10.1111/jon.12687. Epub 2020 Jan 10. J Neuroimaging. 2020. PMID: 31925884 Free PMC article. Review.
-
Combining hyperintense FLAIR rim and radiological features in identifying IDH mutant 1p/19q non-codeleted lower-grade glioma.Eur Radiol. 2022 Jun;32(6):3869-3879. doi: 10.1007/s00330-021-08500-w. Epub 2022 Jan 25. Eur Radiol. 2022. PMID: 35079884
-
The Role of the T2-FLAIR Mismatch Sign as an Imaging Marker of IDH Status in a Mixed Population of Low- and High-Grade Gliomas.Brain Sci. 2020 Nov 19;10(11):874. doi: 10.3390/brainsci10110874. Brain Sci. 2020. PMID: 33228171 Free PMC article.
-
Prognostic Factors of Low-Grade Gliomas in Adults.Curr Oncol. 2022 Sep 30;29(10):7327-7342. doi: 10.3390/curroncol29100576. Curr Oncol. 2022. PMID: 36290853 Free PMC article.
-
Radiological evaluation of ex novo high grade glioma: velocity of diametric expansion and acceleration time study.Radiol Oncol. 2020 Dec 3;55(1):26-34. doi: 10.2478/raon-2020-0071. Radiol Oncol. 2020. PMID: 33885243 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical